20170417-三星证券-Samsung_Healthcare_Weekly_16页_1007kb
报告摘要
Samsung Healthcare Weekly Summary
Core Content
This report provides an update on the performance of various healthcare sectors and companies, both in South Korea and globally. It includes data on market indices, price-to-earnings (P/E) ratios, price-to-book (P/B) ratios, and share price changes across different timeframes. The report is prepared by Samsung Securities and is based on data from QuantiWise, Bloomberg, and DataStream.
Key Analysts and Contact Information
-
Brian Lee - Team Head (Pharm/Biotech)
Email: brian79.lee@samsung.com
Phone: 822 2020 7177 -
SunYoung Yoon - Analyst (Pharm/Biotech)
Email: sy85.yoon@samsung.com
Phone: 822 2020 7840 -
Kevin Kim - Analyst (Medical Devices)
Email: kevin88.kim@samsung.com
Phone: 822 2020 7178 -
Wonyong Park - Research Associate
Email: wkrw.park@samsung.com
Phone: 822 2020 7847
Global Healthcare Indices Overview
| Country | Index | Forward P/E (x) | Portion of Market Cap (%) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) |
|---|---|---|---|---|---|---|---|
| Korea | KRX Health Care | 34.2 | 5.0 | (1.6) | 2.5 | (1.6) | (3.6) |
| Korea | Kospi Medical Supplies | 43.8 | 2.3 | (0.9) | 4.1 | 6.3 | 4.9 |
| Korea | Kosdaq Pharmaceuticals | 25.9 | 2.2 | (2.0) | 0.5 | (4.1) | (6.8) |
| Korea | Kosdaq Medical and Precision Machines | 16.2 | 0.5 | (1.0) | 1.7 | (5.7) | (5.6) |
| US | S&P 500 Healthcare | 16.1 | 8.5 | (0.4) | (2.0) | 4.3 | 7.3 |
| US | S&P 500 Pharma/Biotech | 15.5 | 5.2 | (0.3) | (2.4) | 3.9 | 6.0 |
| US | Nasdaq Biotechnology | 44.2 | 2.4 | 0.9 | (2.4) | 3.8 | 9.8 |
| US | S&P 500 Healthcare Equipment and Services | 17.2 | 3.3 | (0.6) | (1.2) | 4.9 | 9.3 |
| Europe | MSCI Europe Healthcare | 16.4 | 11.3 | 0.7 | 0.7 | 5.7 | 6.3 |
| Europe | MSCI Europe Pharm/Bio | 15.9 | 9.8 | 0.5 | 0.4 | 5.6 | 6.4 |
| Europe | MSCI Europe Healthcare Equipment and Services | 21.9 | 1.5 | 1.9 | 3.0 | 6.7 | 4.8 |
| Japan | MSCI Japan Healthcare | 22.9 | 7.4 | (2.5) | (4.3) | (1.8) | (2.7) |
| Japan | MSCI Japan Pharm/Bio | 23.0 | 5.4 | (2.4) | (4.0) | (2.0) | (2.6) |
| Japan | Topix Pharma | 22.7 | 4.9 | (2.3) | (4.1) | (2.1) | (2.5) |
| Japan | MSCI Japan Healthcare Equipment and Services | 22.4 | 2.0 | (2.7) | (4.9) | (1.3) | (2.9) |
| China | MSCI China Healthcare | 18.8 | 1.6 | (1.1) | 2.0 | 8.7 | 13.7 |
| India | MSCI India Healthcare | 20.1 | 7.4 | 0.8 | (0.8) | 0.8 | 2.7 |
Major Korean Healthcare Firms Performance
Pharmaceutical Holdings
| Company | Ticker | Market Cap (KRWb) | Share Price (KRW) | P/E (2016) | P/E (2017E) | P/B (2016) | P/B (2017E) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) | From Peak (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hanmi Science | 008930 | 3,693 | 59,300 | 449.3 | n/a | 5.4 | n/a | 2.1 | 1.9 | 8.9 | 3.6 | (31.8) |
| Green Cross Holdings | 005250 | 1,476 | 30,050 | 25.0 | n/a | 1.4 | n/a | (3.8) | 13.0 | 31.5 | 26.3 | (3.8) |
| Donga Socio Holdings | 000640 | 865 | 141,000 | 5.5 | n/a | 1.1 | n/a | 2.2 | 14.2 | (5.7) | (9.9) | (13.5) |
| Daewoong | 003090 | 664 | 57,100 | 25.8 | 55.8 | 0.8 | n/a | 14.4 | 33.1 | 29.6 | (0.2) | |
| JW Holdings | 096760 | 497 | 8,100 | n/a | n/a | 4.6 | n/a | 0.5 | (2.1) | (8.8) | (40.7) | |
| Chongkundang Holdings | 001630 | 344 | 68,700 | 11.1 | n/a | 0.9 | n/a | 13.9 | 8.2 | (0.3) | (3.2) |
Pharmaceuticals
| Company | Ticker | Market Cap (KRWb) | Share Price (KRW) | P/E (2016) | P/E (2017E) | P/B (2016) | P/B (2017E) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) | From Peak (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hanmi Pharm | 128940 | 3,377 | 302,500 | 136.7 | 119.1 | 4.8 | 4.9 | 2.2 | 1.9 | 7.5 | 5.9 | (26.0) |
| Yuhan | 000100 | 2,698 | 228,000 | 14.7 | 19.1 | 1.4 | 1.6 | (0.2) | 8.8 | 15.2 | 14.3 | (10.1) |
| Green Cross | 006280 | 1,829 | 156,500 | 29.1 | 30.6 | 1.8 | 1.7 | (3.1) | 3.3 | 4.7 | 13.9 | (2.5) |
| SK Chemicals | 006120 | 1,608 | 63,200 | 22.0 | 13.4 | 1.0 | 0.9 | (2.6) | 3.3 | (3.4) | (5.7) | |
| Young Jin Pharm | 003520 | 1,505 | 8,230 | 372.8 | n/a | 14.8 | n/a | (6.1) | 0.2 | (5.3) | (6.7) | |
| Chong Kun Dang | 185750 | 1,082 | 115,000 | 24.0 | 23.8 | 2.8 | 2.8 | (0.4) | 8.5 | 13.9 | 10.1 | (2.5) |
| Daewoong Pharm | 069620 | 1,010 | 87,200 | 29.5 | 25.0 | 1.4 | 1.7 | (0.3) | 12.2 | 22.3 | 26.9 | (1.5) |
| Bukwang Pharm | 003000 | 943 | 21,150 | 74.4 | n/a | 5.3 | n/a | (2.8) | (2.3) | (11.7) | (19.9) | |
| JW Pharmaceutical | 001060 | 826 | 42,850 | n/a | 113.4 | 4.0 | 3.4 | (4.9) | (4.3) | (14.1) | (18.7) | |
| Donga ST | 170900 | 798 | 94,500 | 83.3 | 47.0 | 1.5 | 1.4 | (1.1) | 0.3 | (3.1) | (10.4) | |
| Samjin Pharm | 005500 | 464 | 33,400 | 16.0 | 13.1 | 2.6 | 2.1 | (2.6) | 5.7 | 2.5 | (3.9) | |
| Kwang Dong Pharm | 009290 | 452 | 8,630 | 15.9 | n/a | 0.9 | n/a | (3.9) | 0.5 | (0.9) | 1.3 | |
| Boryung Pharm | 003850 | 435 | 49,200 | 97.6 | 6.5 | 2.7 | 1.6 | (4.5) | (1.3) | (10.6) | (20.7) | |
| Daewon Pharmaceutical | 003220 | 400 | 21,950 | 17.1 | 14.4 | 2.1 | 2.1 | (1.8) | 9.2 | 21.2 | 15.3 | |
| Huons | 243070 | 330 | 53,300 | 25.6 | 12.8 | 4.2 | 2.7 | (6.1) | (5.3) | (6.7) | (18.5) | |
| Koryo Bio | 196170 | 325 | 29,450 | n/a | n/a | 5.4 | n/a | (14.1) | (12.8) | (23.4) | (25.0) | |
| Kwangdong Bio | 185490 | 320 | 29,450 | n/a | n/a | 5.4 | n/a | (19.1) | (21.7) | (35.4) | (22.6) | |
| Medytox | 086900 | 2,667 | 471,500 | 34.1 | 34.3 | 12.8 | 11.4 | 0.2 | 15.9 | 16.8 | 32.2 | |
| Hugel | 145020 | 1,195 | 364,000 | 24.4 | 20.2 | 4.2 | 3.8 | (5.1) | 1.9 | 11.0 | 13.4 | |
| Caregen | 214370 | 695 | 64,900 | 38.3 | 31.3 | 3.6 | 2.7 | (3.9) | 0.8 | (11.7) | (21.0) | |
| Pharma Research Products | 214450 | 320 | 33,850 | 27.5 | 17.0 | 2.2 | 1.7 | (1.7) | (2.8) | (14.4) | (16.2) | |
| Humedix | 200670 | 263 | 29,450 | 29.1 | 22.1 | 2.7 | 2.1 | (2.8) | 1.9 | (8.4) | (12.2) | |
| Osstem Implant | 048260 | 753 | 52,700 | 36.9 | 23.9 | 8.1 | 4.9 | (2.4) | (1.7) | (7.9) | (13.2) | |
| Viewworks | 100120 | 681 | 68,100 | 22.2 | 19.9 | 5.4 | 4.7 | 0.9 | 2.9 | (2.7) | (13.9) | |
| Dio | 039840 | 500 | 32,950 | 30.3 | 22.3 | 5.4 | 3.7 | (1.8) | 17.5 | (17.6) | (16.7) | |
| Value Added Technology | 043150 | 436 | 29,350 | 21.7 | 15.0 | 3.7 | 2.6 | 1.4 | 11.8 | (18.5) | (18.8) | |
| Interjo | 119610 | 421 | 39,100 | 21.2 | 17.7 | 4.5 | 3.6 | (0.8) | 4.0 | 7.9 | 2.9 | |
| Lutronic | 085370 | 361 | 14,500 | 68.7 | 67.2 | 3.3 | 2.6 | (2.0) | (1.0) | (8.6) | (18.3) | |
| InBody | 041830 | 322 | 23,550 | 21.8 | 15.6 | 4.0 | 2.8 | (1.1) | 4.0 | (8.4) | (12.8) | |
| Rayence | 228850 | 308 | 18,550 | 18.1 | 16.3 | 1.7 | 1.6 | 0.0 | (4.9) | 3.1 | (6.3) | |
| JVM | 054950 | 289 | 45,700 | 24.5 | 16.5 | 2.3 | 2.1 | (1.7) | (2.8) | 8.8 | (6.4) | |
| Sewoon Medical | 100700 | 182 | 4,160 | 22.7 | 16.0 | 2.6 | n/a | (4.6) | 8.6 | (2.2) | (3.9) | |
| Hans Biomed | 042520 | 165 | 16,700 | 37.0 | 23.6 | 3.5 | 3.0 | (0.9) | 2.1 | 2.1 | (2.5) | |
| Huvitz | 065510 | 146 | 12,300 | 14.6 | 11.9 | 2.1 | 1.6 | (0.3) | 8.1 | (9.4) | (12.9) | |
| Coretec | 104540 | 128 | 13,050 | 114.8 | n/a | 2.3 | n/a | (4.0) | 2.0 | (6.1) | (7.8) | |
| Mediana | 041920 | 109 | 12,600 | 17.8 | 12.1 | 3.3 | 2.1 | (4.2) | (4.2) | (17.4) | (23.2) | |
| U&I Corporation | 056090 | 102 | 13,350 | n/a | n/a | 1.2 | n/a | (0.7) | 0.4 | (11.9) | (8.3) | |
| Hironic | 149980 | 92 | 6,530 | 146.6 | n/a | 2.4 | n/a | (0.3) | 8.1 | (9.4) | (12.9) | |
| Meta Biomed | 059210 | 91 | 4,175 | 164.5 | n/a | 2.0 | n/a | (4.6) | 1.6 | (13.7) | (13.5) | |
| CU Medical Systems | 115480 | 49 | 3,390 | n/a | n/a | 1.2 | n/a | (3.1) | 1.5 | (2.3) | (0.9) |
Telemedicine
| Company | Ticker | Market Cap (KRWb) | Share Price (KRW) | P/E (2016) | P/E (2017E) | P/B (2016) | P/B (2017E) | 1-week (%) | 1-month (%) | 3-month (%) | YTD (%) | From Peak (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infinit Healthcare | 071200 | 167 | 6,850 | 23.6 | n/a | 2.4 | n/a | (5.5) | 3.0 | (7.1) | (0.2) | (15.4) |
| UBCare | 032620 | 141 | 3,500 | 27.9 | n/a | 3.0 | n/a | (2.9) | 0.3 | (3.1) | (0.1) | (7.7) |
| BIT Computer | 032850 | 97 | 5,810 | 16.9 | n/a | 2.2 | n/a | (4.4) | 7.4 | 0.2 | 6.0 | (10.6) |
Major Global Healthcare Firms Performance
| Sector | Company | Currency | Market Cap (USDm) | Share Price (local) | P/E (2016) | P/E (2017E) | P/B (2016) | P/B (2017E) | 1-week (%) | 1-month (%) | 3-month (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| US Biotech | Amgen | USD | 118,927 | 162 | 12.6 | 13.2 | 3.6 | 3.4 | (0.4) | (10.3) | 3.5 |
| US Biotech | Celgene | USD | 96,818 | 124 | 29.2 | 17.2 | 13.7 | 9.2 | 0.1 | (1.7) | 5.9 |
| US Biotech | Gilead Sciences | USD | 96,818 | 124 | 29.2 | 17.2 | 13.7 | 9.2 | 0.1 | (1.7) | 5.9 |
Summary of Key Insights
- Market Performance: The global healthcare sector has shown mixed performance, with some indices experiencing declines in the short term but overall positive trends in the long term.
- P/E and P/B Ratios: The forward P/E and P/B ratios indicate varying valuations across regions, with higher valuations in the US and lower in Japan.
- Share Price Trends: The performance of individual companies varies significantly, with some experiencing strong gains while others show declines.
- Sector Breakdown: The report categorizes companies into different sectors such as Pharmaceuticals, Medical Devices, Diagnostics, and Biotech, highlighting their respective performances and valuations.
This summary provides an overview of the current state of the global and Korean healthcare markets, including insights into the performance of various companies and indices.
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
